Effect of Adding Lactoferrin on Oral Iron on Anemia in Chronic Kidney Disease Patients
Anemia of Chronic Kidney Disease
About this trial
This is an interventional treatment trial for Anemia of Chronic Kidney Disease focused on measuring Lactoferrin, Anemia, Chronic Kidney Disease, Oral iron
Eligibility Criteria
Inclusion Criteria: Males and Females aged ≥ 18 years old Patients with eGFR ≥30 and ≤60 mL/min/1.73m2. Absolute iron deficiency anemia (Hgb <10g/dL, serum ferritin <300ng/ml and Transferrin Saturation < 30% ) Exclusion Criteria: Patients on intermittent hemodialysis (IHD) Patients with any known cause of anemia other than iron deficiency or CKD (e.g., sickle cell anemia) Patients who received EPO 4 weeks ago Patients who received IV Iron 8 weeks ago Patients who received blood Transfusion 8 weeks ago Current history of GI bleeding Malignancy history Pregnancy or lactation in female participants Patients non-adherent to at least 80% of the regimen
Sites / Locations
- Kidney and Urology CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Control
Intervention
Patients in this group will initiate treatment with oral ferrous glycine sulfate (100mg) every other day for 3 months
Patients in this group will initiate treatment with oral lactoferrin (one sachet that contains 100mg) with oral ferrous glycine sulfate (100mg) every other day for 3 months